Early bevacizumab dose and time modifications may affect efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma treatment by F. Rossari, D. Lavacchi, E. Alimenti, C. Soldà, F. Salani, L. Esposito, S. Foti, S. Camera, M. Persano, F. Lo Prinzi, F. Vitiello, E. Pellegrini, M. Bruccoleri, M.D. Rizzato, M. Caccese, I.G. Rapposelli, A. Guidolin, A. De Rosa, L. Antonuzzo, G. Masi, M.A. Iavarone, S. Lonardi, M. Rimini, A. Casadei-Gardini

Subjects: Get full text

Impact of Modifying Lazertinib Doses on Effectiveness and Safety in Patients With EGFR‐Positive Advanced Lung Cancer: A Multicenter, Prospective Observational Cohort Study by Mi‐Hyun Kim, Min Ki Lee, Ji Eun Park, Sun Hyo Park, Tae Won Jang, Chi Young Jung, Insu Kim, Seong Hoon Yoon, June Hong Ahn, Hyun‐Kyung Lee, Jin Han Park, Sun Ha Choi, Jung Seop Eom

Subjects: “…dose modification…”
Get full text

Artificial intelligence generated 3D body composition predicts dose modifications in patients undergoing neoadjuvant chemotherapy for rectal cancer by Alex Besson, Ke Cao, Ahmed Mardinli, Lara Wirth, Josephine Yeung, Rory Kokelaar, Peter Gibbs, Fiona Reid, Justin M. Yeung

Subjects: Get full text

Off-the-shelf medication transformed: Custom-dosed metoprolol tartrate tablets via semisolid extrusion additive manufacturing and the perception of this technique in a hospital con... by Valerie R. Levine, Mattias Paulsson, Maria Strømme, Julian Quodbach, Jonas Lindh

Subjects: Get full text

Real world data of cabozantinib in patients with hepatocellular carcinoma: Focusing on dose setting and modification by Hironao Okubo, Hitoshi Ando, Shunsuke Nakamura, Yusuke Takasaki, Koichi Ito, Yuka Fukuo, Kenichi Ikejima, Hiroyuki Isayama

Subjects: Get full text

Impaired liver function: effect on paclitaxel toxicity, dose modifications and overall survival by Marieke Schmidt, Robin Vernooij, Merel van Nuland, Erin Smeijsters, Lot Devriese, Nadia Haj Mohammad, Thom Hermens, Julian Stammers, Christina Swart, Toine Egberts, Saskia Haitjema, Laureen Lammers

Subjects: Get full text

European standard clinical practice recommendations for primary pediatric low-grade gliomas by Kleoniki Roka, Katrin Scheinemann, Shivaram Avula, John H. Maduro, Ulrich W. Thomale, Astrid Sehested, A.Y.N. Schouten-Van Meeteren

Subjects: Get full text

Real-world palbociclib dose modifications and clinical outcomes in patients with HR+/HER2− metastatic breast cancer: A Flatiron Health database analysis by Rachel M. Layman, Xianchen Liu, Benjamin Li, Lynn McRoy, Adam Brufsky

Subjects: Get full text